Catalyst Wire Dossier Catalyst Wire Dossier

ensatinib

ensatinib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ensatinib, covering 2022-01-05 to 2022-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance [Phase 2]

See pricing